CANNAPHARMARX, INC. (CPMD) › Cash & EquivalentsCANNAPHARMARX, INC. (CPMD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $1002011: $252012: $252013: $02014: $1.61M2015: $2.6K2016: $02017: $02018: $464.1K2019: $1.5K2020: $335.0K2021: $27.8K2022: $2.3K2023: $6502024: $2.2K2025: $1.8K$1.8K2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.8K-16.3%2024$2.2K+231.7%2023$650-71.9%2022$2.3K-91.7%2021$27.8K-91.7%2020$335.0K+21552.8%2019$1.5K-99.7%2018$464.1K—2017$0—2016$0-100.0%2015$2.6K-99.8%2014$1.61M—2013$0-100.0%2012$25+0.0%2011$25-75.0%2010$100—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share